Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Contraceptive agents

Oral contraceptives protective against ligament injury in young women

Young women who are at risk of an anterior cruciate ligament tear may benefit from the protective effects conferred by taking oral contraceptive pills, research has suggested.

ACL tear CT scan SPL19

Source: Du Cane Medical Imaging Ltd / Science Photo Library

Researchers concluded that oral contraceptive pills should be considered for elite high school and college-aged female athletes who are at risk of an anterior cruciate ligament tear

Oral contraceptive pills (OCPs) may be protective against anterior cruciate ligament (ACL) tears in women, particularly in 15–19 year olds, a study has shown[1].

The researchers looked at data on 82,874 female patients aged 15–49 years who experienced an ACL tear while taking OCPs for at least one year, compared with an equal number of matched patients with an ACL tear who were not taking OCPs.

They found that 0.56% of people using OCPs required surgical reconstruction compared with 0.69% of those not using OCPs, equivalent to an 18% reduced risk. When stratified by age, OCPs had a protective effect against ACL reconstruction in people aged 15–19 years, but not in age groups above 20 years.

In 15–19-year-olds taking OCPs, there was a 63% reduction in tears, compared to the non-OCP group.

The researchers said that other smaller studies had found similar results and that ongoing randomised trials could help to provide further clinical evidence.

“While clinical evidence is limited, there should be consideration for OCP usage in elite high school and college-aged athletes, especially those who are at risk of ACL tear,” they concluded in The Physician and Sportsmedicine (1 April 2019).

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206578

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.